-
EP3508200
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3508200
| EP3508200 - AQUEOUS FORMULATION CONTAINING 5-AMINOLEVULINIC ACID OR THE LIKE [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 08.03.2024 Database last updated on 14.06.2024 | |
| Former | Grant of patent is intended Status updated on 29.10.2023 | ||
| Former | Examination is in progress Status updated on 05.05.2023 | ||
| Former | Request for examination was made Status updated on 07.06.2019 | ||
| Former | The international publication has been made Status updated on 10.03.2018 | Most recent event Tooltip | 08.03.2024 | (Expected) grant | published on 10.04.2024 [2024/15] | Applicant(s) | For all designated states SBI Pharmaceuticals Co., Ltd. 6-1, Roppongi 1-chome Minato-ku Tokyo 106-6020 / JP | [2019/28] | Inventor(s) | 01 /
MORISHITA, Mika c/o SBI Pharmaceuticals Co., Ltd. 1-5-2 Minatojima-Minamimachi Chuo-ku Kobe-shi Hyogo 650-0047 / JP | 02 /
OTA, Urara c/o SBI Pharmaceuticals Co., Ltd. 1-5-2 Minatojima-Minamimachi Chuo-ku Kobe-shi Hyogo 650-0047 / JP | 03 /
ISHIZUKA, Masahiro c/o SBI Pharmaceuticals Co., Ltd. 6-1, Roppongi 1-chome Minato-ku Tokyo 106-6020 / JP | [2024/15] |
| Former [2019/28] | 01 /
MORISHITA, Mika c/o SBI Pharmaceuticals Co. Ltd. 1-5-2 Minatojima-Minamimachi Chuo-ku Kobe-shi Hyogo 650-0047 / JP | ||
| 02 /
OTA, Urara c/o SBI Pharmaceuticals Co. Ltd. 1-5-2 Minatojima-Minamimachi Chuo-ku Kobe-shi Hyogo 650-0047 / JP | |||
| 03 /
ISHIZUKA, Masahiro c/o SBI Pharmaceuticals Co. Ltd. 6-1 Roppongi 1-chome Minato-ku Tokyo 106-6020 / JP | Representative(s) | Weickmann & Weickmann PartmbB Postfach 860 820 81635 München / DE | [2024/15] |
| Former [2019/28] | Weickmann & Weickmann PartmbB Postfach 860 820 81635 München / DE | Application number, filing date | 17846245.3 | 23.08.2017 | [2019/28] | WO2017JP30107 | Priority number, date | JP20160171753 | 02.09.2016 Original published format: JP 2016171753 | [2019/28] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018043240 | Date: | 08.03.2018 | Language: | JA | [2018/10] | Type: | A1 Application with search report | No.: | EP3508200 | Date: | 10.07.2019 | Language: | EN | [2019/28] | Type: | B1 Patent specification | No.: | EP3508200 | Date: | 10.04.2024 | Language: | EN | [2024/15] | Search report(s) | International search report - published on: | JP | 08.03.2018 | (Supplementary) European search report - dispatched on: | EP | 17.03.2020 | Classification | IPC: | A61K31/197, A61K31/22, A61K31/221, A61K31/222, A61K31/295, A61K9/06, A61K9/08, A61K47/02, A61K47/12 | [2020/16] | CPC: |
A61K31/197 (EP,US);
A61K9/08 (US);
A61K31/22 (EP,US);
A61K31/221 (EP);
A61K31/222 (EP);
A61K31/295 (EP,US);
A61K47/02 (EP,US);
A61K47/12 (EP,US);
A61K9/06 (EP,US);
A61P35/00 (EP);
A61P39/02 (EP);
A61P43/00 (EP);
A61P7/06 (EP)
(-)
| C-Set: |
A61K31/197, A61K2300/00 (EP);
A61K31/221, A61K2300/00 (EP);
A61K31/222, A61K2300/00 (EP);
A61K31/22, A61K2300/00 (EP); |
| Former IPC [2019/28] | A61K31/197, A61K9/06, A61K9/08, A61K31/22, A61K47/02, A61K47/12 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/28]
| Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | WÄSSRIGE FORMULIERUNG MIT 5-AMINOLEVULINSÄURE ODER DERGLEICHEN | [2019/28] | English: | AQUEOUS FORMULATION CONTAINING 5-AMINOLEVULINIC ACID OR THE LIKE | [2019/28] | French: | FORMULATION AQUEUSE CONTENANT DE L'ACIDE 5-AMINOLÉVULINIQUE OU SIMILAIRE | [2019/28] | Entry into regional phase | 26.02.2019 | Translation filed | 26.02.2019 | National basic fee paid | 26.02.2019 | Search fee paid | 26.02.2019 | Designation fee(s) paid | 26.02.2019 | Examination fee paid | Examination procedure | 26.02.2019 | Examination requested [2019/28] | 10.06.2020 | Amendment by applicant (claims and/or description) | 09.05.2023 | Despatch of a communication from the examining division (Time limit: M04) | 14.06.2023 | Reply to a communication from the examining division | 30.10.2023 | Communication of intention to grant the patent | 29.02.2024 | Fee for grant paid | 29.02.2024 | Fee for publishing/printing paid | 29.02.2024 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 28.06.2019 | Renewal fee patent year 03 | 30.07.2020 | Renewal fee patent year 04 | 29.07.2021 | Renewal fee patent year 05 | 01.08.2022 | Renewal fee patent year 06 | 31.07.2023 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]JP2010095479 (MILBON CO LTD, et al) [Y] 1-9 * abstract *; | [X]EP2767278 (SBI PHARMACEUTICALS CO LTD [JP], et al) [X] 1-9 * page 4, paragraph 12 * * page 7, paragraphs 27-33 * * example 4; tables 1-2 *; | [X]EP2767277 (SBI PHARMACEUTICALS CO LTD [JP], et al) [X] 1-4,6-9 * page 3, paragraphs 13-14 * * page 5, paragraphs 36-42 * * page 7, paragraph 58 *; | [I]WO2015129535 (UNIV OCCUPATIONAL AND ENVIRONMENTAL HEALTH JAPAN [JP], et al) [I] 1-9 * abstract *; | [YP]US2017056351 (NISHIZAWA SHIGERU [JP], et al) [YP] 1-9 * pages 2-3, paragraph 23 * * page 5, paragraphs 57-60 * * page 7, paragraph 84 - page 8, paragraph 87 ** example 1 * | International search | [Y]JPH08175986 (JOHNSON & JOHNSON MEDICAL) [Y] 1-9 * , claims; paragraphs [0001], [0029] & EP 704209 A1 claims; [1.Field of the Invention]; example 1 *; | [Y]JPH1112197 (COSMO SOGO KENKYUSHO KK, et al) [Y] 1-9 * , claims; example 1 & US 2003/0065029 A1 claims; example 1 & WO 1998/057668 A1 & EP 995448 A1 *; | [Y]JP2001518498 (Medac Gesellschaft fur Klinische Spezialpraparate mbH) [Y] 1-9 * , claims; paragraph [0022] & WO 1999/017764 A1 & EP 1019037 A1 *; | [Y]JP2011016753 (SBI ALAPROMO CO LTD) [Y] 1-9 * , claims; paragraph [0022] (Family: none) *; | [X]CN105878225 (YE ZHIFAN, et al) [X] 1-9* , claims; paragraphs [0017] to [0019], [0062] to [0065] (Family: none) * |